84 related articles for article (PubMed ID: 4631717)
1. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
Oger J; Cloarec L; Chatel M; Sabouraud O
Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
[No Abstract] [Full Text] [Related]
2. [The effect of azathioprine treatment on IgG subclasses in multiple sclerosis].
Losy J; Michałowska-Wender G; Wender M
Neurol Neurochir Pol; 1993; 27(1):39-44. PubMed ID: 8502358
[TBL] [Abstract][Full Text] [Related]
3. [Effects of prednisone and azathioprine treatment on oligoclonal IGG in the cerebrospinal fluid of multiple sclerosis patients. Preliminary communication].
Losy J; Karolewska J; Wender M
Neurol Neurochir Pol; 1996; 30(2):201-11. PubMed ID: 8756247
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.
Staugaitis SM; Shapshak P; Myers LW; Ellison GW; Tourtellotte WW; Lee M
Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418
[TBL] [Abstract][Full Text] [Related]
5. Azathioprine reduces intrathecal IgG synthesis in multiple sclerosis.
Caputo D; Zaffaroni M; Ghezzi A; Cazzullo CL
Acta Neurol Scand; 1987 Feb; 75(2):84-6. PubMed ID: 3577680
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
Frick E; Angstwurm H; Strauss G
MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
[No Abstract] [Full Text] [Related]
7. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
Dachsel R; Köppel C
Psychiatr Neurol Med Psychol (Leipz); 1989 Jul; 41(7):420-5. PubMed ID: 2772076
[TBL] [Abstract][Full Text] [Related]
8. [Long-term therapeutic trials and multiple sclerosis: a wager?].
Confavreux C
Rev Neurol (Paris); 1983; 139(6-7):431-7. PubMed ID: 6412341
[No Abstract] [Full Text] [Related]
9. [Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].
Aimard G; Confavreux C; Trouillas P; Devic M
Rev Neurol (Paris); 1978 Mar; 134(3):215-22. PubMed ID: 360353
[No Abstract] [Full Text] [Related]
10. The clinical value of commonly used spinal fluid diagnostic studies in the evaluation of patients with suspected multiple sclerosis.
Brasher GW; Follender AB; Spiekerman AM
Am J Manag Care; 1998 Aug; 4(8):1119-21. PubMed ID: 10182887
[TBL] [Abstract][Full Text] [Related]
11. [Haematological changes following long-term treatment of multiple sclerosis and myasthenia with azathioprin (author's transl)].
Haas J; Patzold U
Nervenarzt; 1982 Feb; 53(2):105-9. PubMed ID: 6801533
[No Abstract] [Full Text] [Related]
12. [Role of isoelectric focusing of cerebrospinal fluid immunoglobulin G in the early biological assessment of multiple sclerosis].
Caudie C; Allauzen O; Bancel J; Later R
Ann Biol Clin (Paris); 2000; 58(2):187-93. PubMed ID: 10760705
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
Kappos L
Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
[No Abstract] [Full Text] [Related]
14. [Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].
Hommes OR
Ned Tijdschr Geneeskd; 1976 Mar; 120(10):424-30. PubMed ID: 765862
[No Abstract] [Full Text] [Related]
15. CSF immunoglobulins G in multiple sclerosis.
Caputo D; Zaffaroni M; Procaccia S
Boll Ist Sieroter Milan; 1982; 61(5):393-403. PubMed ID: 6927183
[TBL] [Abstract][Full Text] [Related]
16. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L
Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
[No Abstract] [Full Text] [Related]
17. Azathioprine and methotrexate in multiple sclerosis.
Fernández O; Fernández V; De Ramón E
J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
[TBL] [Abstract][Full Text] [Related]
18. [Immunoglobulin G synthesizing lymphocytes in the cerebrospinal fluid in multiple sclerosis and non-inflammatory diseases of the nervous system].
Schädlich HJ; Bliersbach Y; Felgenhauer K; Schifferdecker M
J Clin Chem Clin Biochem; 1984 Jul; 22(7):483-7. PubMed ID: 6481312
[TBL] [Abstract][Full Text] [Related]
19. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cerebrospinal fluid and serum of patients with multiple sclerosis by means of anti-idiotypic antisera.
Nagelkerken LM; van Zoonen-van Exel M; van Walbeek HK; Aalberse RC; Out TA
J Immunol; 1982 Mar; 128(3):1102-6. PubMed ID: 6173419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
